Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. W. Jones, A. Agusti, E. D. Bateman, D. Singh, R. Lamarca, G. de Miquel, C. Caracta, E. Garcia Gil (London, Manchester, United Kingdom; Barcelona, Spain; Cape Town, South Africa; , United States Of America). Aclidinium bromide in patients with chronic obstructive pulmonary disease: Improvement in health status in ATTAIN. Eur Respir J 2011; 38: Suppl. 55, 877

Member's Comments

No comment yet.

Related content which might interest you: Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Efficacy of tiotropium bromide in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Evaluation of health quality of patients with asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - The eclectic world of respiratory nursing Year: 2011 Long-term health status in patients with poorly reversible chronic obstructive pulmonary disease (COPD) treated with cilomilast Source: Eur Respir J 2004; 24: Suppl. 48, 540s Year: 2004 The ATTAIN study: Safety and tolerability of aclidinium bromide in chronic obstructive pulmonary disease Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 Effects of tiotropium bromide in exercise tolerance in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Predictors of health status in chronic obstructive pulmonary disease patients over three years Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Tiotropium in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 205-206 Year: 2002 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Impact of integrated care on health status in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008